Your browser doesn't support javascript.
loading
Treatment strategy at the decision for allogeneic transplantation in patients with myelodysplastic syndrome in the era of azacitidine: A KSGCT prospective study.
Kako, Shinichi; Kimura, Shun-Ichi; Wada, Hidenori; Komiya, Yusuke; Nakasone, Hideki; Sakurai, Masatoshi; Kato, Jun; Tanaka, Masatsugu; Fujii, Eriko; Tachibana, Takayoshi; Yamamoto, Wataru; Hagihara, Maki; Watanabe, Reiko; Yokota, Akira; Nakano, Hirofumi; Mori, Takehiko; Nakaseko, Chiaki; Kanamori, Heiwa; Okamoto, Shinichiro; Kanda, Yoshinobu.
Afiliação
  • Kako S; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan. Electronic address: shinichikako@asahi-net.email.ne.jp.
  • Kimura SI; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Wada H; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Komiya Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Nakasone H; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
  • Sakurai M; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Kato J; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Tanaka M; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Fujii E; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Tachibana T; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Yamamoto W; Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan.
  • Hagihara M; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan.
  • Watanabe R; Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Yokota A; Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan.
  • Nakano H; Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan.
  • Mori T; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan; Department of Hematology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Nakaseko C; Department of Hematology, Chiba University Hospital, Chiba, Japan; Department of Hematology, International University of Health and Welfare, Narita, Japan.
  • Kanamori H; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Okamoto S; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Kanda Y; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan.
Leuk Res ; 133: 107371, 2023 10.
Article em En | MEDLINE | ID: mdl-37595372
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Leuk Res Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Leuk Res Ano de publicação: 2023 Tipo de documento: Article